Treatment for Cannabinoid Hyperemesis Syndrome Unresponsive to Metoclopramide
Haloperidol (0.5-2 mg IV or PO every 4-6 hours) is the most effective first-line pharmacological treatment for cannabinoid hyperemesis syndrome (CHS) that has not responded to metoclopramide. 1
First-Line Treatment Options
When metoclopramide (Reglan) has failed to control symptoms in CHS, consider:
Dopamine receptor antagonists:
- Haloperidol 0.5-2 mg IV or PO every 4-6 hours 1
- Monitor for extrapyramidal side effects
Topical capsaicin cream (0.1%):
- Apply to the abdomen for symptomatic relief 1
- Works by activating TRPV1 receptors, which may help regulate the endocannabinoid system
Benzodiazepines:
Second-Line Treatment Options
If first-line treatments fail to provide relief:
- Olanzapine: 5-10 mg PO daily 1
- Corticosteroids: For short-term use in severe cases 1
- Antiepileptics: Zonisamide and levetiracetam have shown some efficacy 3
Supportive Measures
- IV fluid rehydration: Essential for correcting dehydration 1
- Hot showers/baths: Consistently reported as providing temporary relief 1, 3
- Quiet, supportive environment: Minimize stimulation during acute episodes 1
Treatment Algorithm
- Start with haloperidol 0.5-2 mg IV/PO AND topical capsaicin
- If inadequate response within 1-2 hours, add lorazepam 0.5-2 mg
- Ensure adequate hydration with IV fluids
- For persistent symptoms, consider olanzapine or corticosteroids
- Emphasize the importance of cannabis cessation as the definitive treatment
Important Considerations
- Avoid opioids: They can worsen nausea and have high addiction potential in this population 1
- Limited efficacy of traditional antiemetics: Standard antiemetics like ondansetron may provide only minimal benefit 1, 3
- Definitive treatment: Complete cannabis cessation for at least 3-6 months is necessary for full resolution 1
Special Populations
For adolescents with CHS, a combination of haloperidol (5 mg IV) with either lorazepam (2 mg IV) or topical capsaicin (0.025%) has shown effectiveness 4.
Common Pitfalls
- Misdiagnosis: CHS is often misdiagnosed, leading to unnecessary testing and ineffective treatments. Look for the triad of chronic cannabis use, cyclic vomiting, and relief with hot showers 1
- Relying on conventional antiemetics: Traditional antiemetics often fail in CHS 5
- Failure to address cannabis use: Without addressing the underlying cause through cannabis cessation, symptoms will likely recur 1
Remember that while pharmacological interventions can provide symptomatic relief during acute episodes, complete resolution of CHS requires cannabis cessation, which should be emphasized as part of the treatment plan.